Atreca, Inc.

OTCPK:BCEL Stock Report

Market Cap: US$3.6m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Atreca Management

Management criteria checks 3/4

Atreca's CEO is John Orwin, appointed in Apr 2018, has a tenure of 6.17 years. total yearly compensation is $927.03K, comprised of 64.8% salary and 35.2% bonuses, including company stock and options. directly owns 0.2% of the company’s shares, worth $6.98K. The average tenure of the management team and the board of directors is 5 years and 5.5 years respectively.

Key information

John Orwin

Chief executive officer

US$927.0k

Total compensation

CEO salary percentage64.8%
CEO tenure6.2yrs
CEO ownership0.2%
Management average tenure5yrs
Board average tenure5.5yrs

Recent management updates

Recent updates

Here's Why We're A Bit Worried About Atreca's (NASDAQ:BCEL) Cash Burn Situation

Jul 23
Here's Why We're A Bit Worried About Atreca's (NASDAQ:BCEL) Cash Burn Situation

Can Atreca (NASDAQ:BCEL) Afford To Invest In Growth?

Dec 08
Can Atreca (NASDAQ:BCEL) Afford To Invest In Growth?

Atreca GAAP EPS of -$0.72 misses by $0.02

Aug 08

Here's Why We're A Bit Worried About Atreca's (NASDAQ:BCEL) Cash Burn Situation

Jun 18
Here's Why We're A Bit Worried About Atreca's (NASDAQ:BCEL) Cash Burn Situation

Atreca: Biotech With Promise Based On First Candidate ATRC-101

Apr 22

Is Atreca (NASDAQ:BCEL) In A Good Position To Invest In Growth?

Mar 05
Is Atreca (NASDAQ:BCEL) In A Good Position To Invest In Growth?

Atreca: Overvalued, Then Undervalued, Now Under Pressure - Making The Buy Case

Jan 25

Atreca: Safety Data Brought Down Stock

Sep 10

Is Atreca (NASDAQ:BCEL) In A Good Position To Invest In Growth?

Sep 02
Is Atreca (NASDAQ:BCEL) In A Good Position To Invest In Growth?

We Think Atreca (NASDAQ:BCEL) Can Afford To Drive Business Growth

May 14
We Think Atreca (NASDAQ:BCEL) Can Afford To Drive Business Growth

Need To Know: Atreca, Inc. (NASDAQ:BCEL) Insiders Have Been Buying Shares

Jan 29
Need To Know: Atreca, Inc. (NASDAQ:BCEL) Insiders Have Been Buying Shares

We Think Atreca (NASDAQ:BCEL) Can Afford To Drive Business Growth

Dec 07
We Think Atreca (NASDAQ:BCEL) Can Afford To Drive Business Growth

Atreca EPS misses by $0.06

Nov 12

CEO Compensation Analysis

How has John Orwin's remuneration changed compared to Atreca's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2023n/an/a

-US$98m

Jun 30 2023n/an/a

-US$85m

Mar 31 2023n/an/a

-US$93m

Dec 31 2022US$927kUS$601k

-US$97m

Sep 30 2022n/an/a

-US$105m

Jun 30 2022n/an/a

-US$110m

Mar 31 2022n/an/a

-US$108m

Dec 31 2021US$4mUS$583k

-US$109m

Sep 30 2021n/an/a

-US$103m

Jun 30 2021n/an/a

-US$98m

Mar 31 2021n/an/a

-US$92m

Dec 31 2020US$5mUS$567k

-US$86m

Sep 30 2020n/an/a

-US$83m

Jun 30 2020n/an/a

-US$76m

Mar 31 2020n/an/a

-US$74m

Dec 31 2019US$845kUS$507k

-US$67m

Sep 30 2019n/an/a

-US$59m

Jun 30 2019n/an/a

-US$53m

Mar 31 2019n/an/a

-US$44m

Dec 31 2018US$5mUS$319k

-US$38m

Compensation vs Market: John's total compensation ($USD927.03K) is above average for companies of similar size in the US market ($USD678.50K).

Compensation vs Earnings: John's compensation has been consistent with company performance over the past year.

CEO

John Orwin (59 yo)

6.2yrs

Tenure

US$927,033

Compensation

Mr. John A. Orwin, M.B.A. serves as Chairman of the Board for Nested Therapeutics since February 2024. He serves as Independent Chairman of the Board of AnaptysBio, Inc. since September 15, 2023. He has be...

Leadership Team

NamePositionTenureCompensationOwnership
John Orwin
President6.2yrsUS$927.03k0.20%
$ 7.0k
Tito Serafini
Founder & Directorno dataUS$665.50k0.81%
$ 29.0k
Rick Ruiz
Principal Accounting Officerless than a yearno datano data
Courtney Phillips
General Counsel & Corporate Secretary5yrsno data0.073%
$ 2.6k
Roger Ruiz
Vice President of Financeno datano data0.067%
$ 2.4k

5.0yrs

Average Tenure

59.5yo

Average Age

Experienced Management: BCEL's management team is seasoned and experienced (5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
John Orwin
President6.2yrsUS$927.03k0.20%
$ 7.0k
Tito Serafini
Founder & Director14.4yrsUS$665.50k0.81%
$ 29.0k
Brian Atwood
Independent Chairman of the Board10.5yrsUS$97.77k0.13%
$ 4.5k
Lawrence Steinman
Chairman of External Scientific Advisory Board & Technical Advisor4.8yrsUS$150.00kno data
Kristine Ball
Independent Director4.1yrsUS$64.27k0%
$ 0
William Robinson
Director13.4yrsUS$312.77k0.93%
$ 33.2k
David Lacey
Independent Director8.1yrsUS$70.77k0%
$ 0
Stephen Brady
Independent Director2.9yrsUS$60.27k0%
$ 0
Douglas Crawford
Board Observerno datano datano data
Andrew Farnum
Board Observerno datano datano data
Lindsey Rolfe
Independent Director4.8yrsUS$62.77k0%
$ 0
Stacey Ma
Independent Director2.9yrsUS$57.77k0%
$ 0

5.5yrs

Average Tenure

57.5yo

Average Age

Experienced Board: BCEL's board of directors are considered experienced (5.5 years average tenure).